for inadequate response to or intolerance of NSAIDs and/or glucocorticoids for systemic JIA without MAS. Most physicians and patients/caregivers preferred quickly starting IL-1 or IL-6 inhibitors for insufficient response to NSAIDs or glucocorticoids Biologic DMARDs or conventional synthetic DMARDs are strongly recommended over long-term glucocorticoids for residual arthritis and incomplete response to IL-1 and/or IL-6 inhibitors. There is no preferred agent. Given the potential toxicities from long-term use of glucocorticoids Systemic JIA with MAS: initial therapy (Table 6 Infections can trigger MAS; therefore, all persons with MAS should be evaluated for infection concurrently with or prior to initiation of therapy Biologic DMARDs IL-1 or IL-6 inhibitors are conditionally recommended over calcineurin inhibitors alone to achieve inactive disease and resolution of MAS for systemic JIA with MAS. There is no preferred agent. IL-1 and IL-6 inhibitors have proven to be very helpful in the